Survival of patients with metastatic breast cancer with or without locoregional therapy - Authors' reply

Affiliations

¹ Department of Surgical Oncology, Tata Memorial Centre, Mumbai 400012, India. Electronic address: badwera@tmc.gov.in.
² Department of Medical Oncology, Tata Memorial Centre, Mumbai 400012, India.
³ Department of Surgical Oncology, Tata Memorial Centre, Mumbai 400012, India.
⁴ Breast Cancer Working Group, Tata Memorial Centre, Mumbai 400012, India.

Comment

Rajendra Badwe et al. Lancet Oncol. 2015 Dec.

. 2015 Dec;16(16):e587-8.

doi: 10.1016/S1470-2045(15)00479-9.

¹ Department of Surgical Oncology, Tata Memorial Centre, Mumbai 400012, India. Electronic address: badwera@tmc.gov.in.
² Department of Medical Oncology, Tata Memorial Centre, Mumbai 400012, India.
³ Department of Surgical Oncology, Tata Memorial Centre, Mumbai 400012, India.
⁴ Breast Cancer Working Group, Tata Memorial Centre, Mumbai 400012, India.

No abstract available

Comment on

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S. Badwe R, et al. Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9. Lancet Oncol. 2015. PMID: 26363985 Clinical Trial.
Survival of patients with metastatic breast cancer with or without locoregional therapy.
Fouad TM. Fouad TM. Lancet Oncol. 2015 Dec;16(16):e585-6. doi: 10.1016/S1470-2045(15)00445-3. Lancet Oncol. 2015. PMID: 26678204 No abstract available.
Survival of patients with metastatic breast cancer with or without locoregional therapy.
Gounaris I. Gounaris I. Lancet Oncol. 2015 Dec;16(16):e585. doi: 10.1016/S1470-2045(15)00367-8. Lancet Oncol. 2015. PMID: 26678205 No abstract available.
Survival of patients with metastatic breast cancer with or without locoregional therapy.
Honda K, Gyawali B, Ando Y. Honda K, et al. Lancet Oncol. 2015 Dec;16(16):e586. doi: 10.1016/S1470-2045(15)00368-X. Lancet Oncol. 2015. PMID: 26678206 No abstract available.
Survival of patients with metastatic breast cancer with or without locoregional therapy.
Biswas B, Dabkara D, Ganguly S. Biswas B, et al. Lancet Oncol. 2015 Dec;16(16):e586-7. doi: 10.1016/S1470-2045(15)00453-2. Lancet Oncol. 2015. PMID: 26678207 No abstract available.